Preclinical pharmacokinetics and antitumor activity of imexon Robert T. DorrJames D. LiddilEvan M. Hersh Brief Report Pages: 113 - 116
Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming unitsin vitro Henrik DepenbrockMartin WengerAxel -R. Hanauske OriginalPaper Pages: 117 - 123
Activity of the morpholino anthracycline 3′-deamino-3′-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming unitsin vitro A. A. Ebrahim El-ZayatMiguel A. IzquierdoDaniel D. Von Hoff OriginalPaper Pages: 125 - 131
Phase I and pharmacokinetic study of KW-2149 given by 24 hours continuous infusion Luc DirixGilles CatimelAllan Van Oosterom OriginalPaper Pages: 133 - 136
Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer Alex Y. ChangZ. Nora TuRonald Blum OriginalPaper Pages: 137 - 141
Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma Milan SlavikP. Y. LiuVernon K. Sondak OriginalPaper Pages: 143 - 147
A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patients with colorectal carcinoma Neal J. MeropolNicholas J. PetrelliPatrick J. Creaven OriginalPaper Pages: 149 - 155
Mitomycin C and menadione for the treatment of lung cancer: a phase II trial Merry TetefKim MargolinJames H. Doroshow OriginalPaper Pages: 157 - 162
Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors Heidi Sonya PucDean F. BajorinRobert J. Motzer Brief Report Pages: 163 - 165
Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer Stephen K. WilliamsonMichael K. WolfE. David Crawford OriginalPaper Pages: 167 - 170
A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma William J. GradisharNicholas J. VogelzangAl. B. Benson III OriginalPaper Pages: 171 - 174
Phase I trial of diaziquone (AZQ) plus GM-CSF Lynn C. HartmannMatthew M. AmesRonald L. Richardson Brief Report Pages: 175 - 176